The University of Utah is paying an outside consulting firm $6 million for its advisors to come in and coach the school on how it could, in turn, save millions of dollars.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

In-depth analysis of market report, which encompasses revenue estimations, key investment opportunities ... For example, in February 2021, Avrio Health, Purdue Pharma L.P.'s subsidiary company, ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

including from its pharmacists and internal data, that it was dispensing unlawful prescriptions. The Justice Department filed a similar suit against Walgreens rival CVS Health in December. Meanwhile, ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street ... migraine drug Legalcategory· January 24, 2025 Purdue Pharma said on Friday it needs more time to build ...

“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Vertex Pharmaceuticals ( VRTX) reported fourth-quarter revenue and offered an outlook for 2025 that topped analysts’ expectations. The company said it anticipates 2025 revenue of $11.75 billion to $12 ...